Characterization of the New Immunosuppressive Drug Undecylprodigiosin in Human Lymphocytes: Retinoblastoma Protein, Cyclin-Dependent Kinase-2, and Cyclin-Dependent Kinase-4 as Molecular Targets

Journal of Immunology

Volumn 158, Issue 8, 1997, Pages 3987-3995

  Songia, Simona ^a   Mortellaro, Alessandra ^a   Taverna, Stefano ^a   Fornasiero, Chiara ^b   Scheiber, Enrico A ^c   Erba, Eugenio ^a   Colotta, Francesco ^b   Mantovani, Alberto ^a   Isetta, Anna Maria ^b   Golay, Josée ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b PFIZER INC   (United States)

^c Bollate Hospital   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CDK2 PROTEIN, HUMAN; CDK4 PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE 2; CYCLIN DEPENDENT KINASE 4; DRUG DERIVATIVE; IMMUNOSUPPRESSIVE AGENT; ONCOPROTEIN; PRODIGIOSIN; PROTEIN SERINE THREONINE KINASE; RETINOBLASTOMA PROTEIN; UNDECYLPRODIGIOSIN;

ARTICLE; CELL CULTURE; DRUG EFFECT; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; LYMPHOCYTE ACTIVATION; METABOLISM; T LYMPHOCYTE;

CDC2-CDC28 KINASES; CELLS, CULTURED; CYCLIN-DEPENDENT KINASE 2; CYCLIN-DEPENDENT KINASE 4; CYCLIN-DEPENDENT KINASES; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; LYMPHOCYTE ACTIVATION; PRODIGIOSIN; PROTEIN-SERINE-THREONINE KINASES; PROTO-ONCOGENE PROTEINS; RETINOBLASTOMA PROTEIN; T-LYMPHOCYTES;

EID: 0031569602     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Calne, R. Y., S. Thiru, P. McMaster, G. N. Craddock, D. J. G. White, D. B. Evans, D. C. Dunn, and B. D. Pentlow. 1978. Cyclosporin A in patients receiving renal allografts from cadaver donors. Lancet 2:1323.
2. Canadian Multicenter Transplant Study Group. 1986. A randomized clinical trial of cyclosporin in cadaveric renal transplantation. N. Engl. J. Med. 314:1219.
3. Sigal, N. H., and F. J. Dumont. 1992. Cyclosporin A, FK-506 and rapamycin: pharmacological probes of lymphocyte signal transduction. Annu. Rev. Immunol. 10:519.
4. Sehgal, S. N., K. Molnar-Kimber, T. D. Ocain, and G. M. Weichman. 1994. Rapamycin: a novel immmunosuppressive macrolide. Med. Res. Rev. 14:1.
5. Thomson, A. W., and T. E. Starzl. 1993. New immunosuppressive drugs: mechanistic insights and potential therapeutic advances. Immunol. Rev. 136:72.
6. Nourse, J., E. Firpo, W. M. Flanagan, S. Coats, K. Polyak, M. H. Lee, J. Massague, G. R. Crabtree, and J. M. Roberts. 1994. Interleukin-2-mediated elimination of the p27kip1 cyclin-dependent kinase inhibitor prevented by rapamycin. Nature 372:570.
7. Tsuji, R. F., M. Yamamoto, A. Nakamura, T. Kataoka, J. Magae, K. Nagai, and M. Yamasaki. 1990. Selective immune-suppression of prodigiosin 25-C and FK506 in the murine immune system. J. Antibiot. (Tokyo) 43:1293.
8. Tsuji, R. F., J. Magae, M. Yamashita, K. Nagai, and M. Yamasaki. 1992. Immunomodulating properties of prodigiosin 25-C an antibiotic which preferentially suppresses induction of cytotoxic T cells. J. Antibiot. (Tokyo) 45:1295.
9. Nakamura, A., J. Magae, R. F. Tsuji, M. Yamasaki, and K. Nagai. 1989. Suppression of cytotoxic T cell induction in vivo by prodigiosin 25-C. Transplantation 47:1013.
10. Golay, J., G. Cusmano, and M. Introna. 1992. Independent regulation of c-myc, B-myb and c-myb gene expression by inducers and inhibitors of proliferation in human B lymphocytes. J. Immunol. 149:300.
11. Clark, E. A., G. Shu, and J. A. Ledbetter. 1985. Role of the Bp35 cell surface polypeptide in human B cell activation. Proc. Natl. Acad. Sci. USA 82:1776.
12. Clark, E. A., and J. A. Ledbetter. 1986. Activation of human B cells mediated through two distinct cell surface differentiation antigens. Proc. Natl. Acad. Sci. USA 83:4494.
13. Golay, J., and D. H. Crawford. 1987. Pathways of human b lymphocyte activation blocked by B-cell specific monoclonal antibodies. Immunology 62:279.
14. - B lymphocytes and in Burkitt's lymphoma cell lines. J. Immunol. 153:543.
15. Golay, J., A. Capucci, M. Arsura, M. Castellano, V. Rizzo, and M. Introna. 1991. Expression of c-myb and B-myb but not A-myb correlates with proliferation in human hematopoietic cells. Blood 77:149.
16. + B-acute lymphoblastic leukemia and a subset of chronic lymphocytic leukemias. Blood 87:1900.
17. Vikhanskaya, F., M. D'Incalci, and M. Broggini. 1996. Changes in cyclins (A, B1, D1, E) levels and in cyclin dependent kinases (cdc2, cdk2 and cdk4) levels and activity induced by DNA damaging agents in a human ovarian cancer cell line expressing mutated or wild type p53. Exp. Cell Res. 227:380.
18. June, C. H., J. A. Ledbetter, P. S. Linsley, and C. B. Thompson. 1990. Role of the CD28 receptor in T cell activation. Immunol. Today 11:211.
19. Alcover, A., D. Ramarli, N. E. Richardson, H. C. Chang, and E. L. Reinherz. 1987. Functional and molecular aspects of human T lymphocyte activation via T3-Ti and T11 pathways. Immunol. Rev. 95:5.
20. Kehry, M. 1996. CD40-mediated signalling in B cells: balancing cell survival, growth and death. J. Immunol. 156:2345.
21. Deans, J. P., G. L. Schieven, G. Shu, M. A. Valentine, L. A. Gilliland, A. Aruffo, E. A. Clark, and J. A. Ledbetter. 1993. Association of tyrosine and serine kinases with the B cell surface antigen CD20. J. Immunol. 151:4494.
22. Deans, J. P., L. Kalt, J. A. Ledbetter, G. L. Schieven, J. B. Bolen, and P. Johnson. 1995. Association of 75/80-kDa phosphoproteins and the tyrosine kinases lyn, fyn, and lck with the B cell molecule CD20. J. Biol. Chem. 270:22632.
23. Thorley-Lawson, D. A. 1988. Basic virological aspects of Epstein-Barr virus infection. Semin. Hematol. 25:247.
24. Golay, J., L. Basilico, L. Loffarelli, S. Songia, V. Broccoli, and M. Introna. 1996. Regulation of hematopoietic cell proliferation and differentiation by the myb oncogene family of transcription factors. Int. J. Clin. Lab. Res. 26:24.
25. Kuo, K., J. Chung, D. F. Fiorentino, W. M. Flanagan, J. Blenis, and G. R. Crabtree. 1992. Rapamycin selectively inhibits interleukin-2 activation of p70 S6 kinase. Nature 358:70.
26. Ajchenbaum, F., K. Ando, J. A. DeCaprio, and J. D. Griffin. 1993. Independent regulation of human D-type cyclin gene expression during G1 phase in primary human T lymphocytes. J. Biol. Chem. 268:4113.
27. Firpo, E. J., A. Koff, M. J. Solomon, and J. M. Roberts. 1994. Inactivation of a cdk2 inhibitor during interleukin 2-induced proliferation of human T lymphocytes. Mol. Cell Biol. 14:4889.
28. Calvo, V., C. M. Crews, T. A. Vik, and B. E. Bierer. 1992. Interleukin 2 stimulation of p70 S6 kinase activity is inhibited by the immunosuppressant rapamycin. Proc. Natl. Acad. Sci. USA 89:7571.
29. Riley, D. J., E. Y. H. P. Lee, and W. H. Lee. 1994. The retinoblastoma protein: more than a tumour suppressor. Annu. Rev. Cell Biol. 10:1.
30. Terada, N., J. J. Lucas, and E. W. Gerfand. 1991. Differential regulation of the tumour suppressor molecules, retinoblastoma susceptibility gene product (Rb) and p53, during cell cycle progression of normal human T cells. J. Immunol. 147:698.
31. Klein, G. 1994. Epstein-Barr virus strategy in normal and neoplastic B cells. Cell 77:791.
32. Granelli-Piperno, A., L. Andrus, and R. M. Steinman. 1986. Lymphokine and non-lymphokine mRNA levels in stimulated human T cells. J. Exp. Med. 163: 922.
33. Reed, J. C., J. D. Alpers, P. C. Nowell, and R. G. Hoover. 1986. Sequential expression of protooncogenes during lectin-stimulated autogenesis of normal human lymphocytes. Proc. Natl. Acad. Sci. USA 83:3982.